Etanercept is a tumor necrosis factor (TNF) blocker used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Plaque psoriasis in adults and children over the age of four, as well as polyarticular juvenile idiopathic arthritis in children over the age of two, are all treated with this drug. The drug is occasionally used with a drug called methotrexate. Manufacturers in several countries, including Y, sell the drug in the form of prefilled syringes (at concentrations of 25mg/0,5ml and 50mg/1,0ml), prefilled pens (at concentration 50 mg/ml), and injection solutions. Etanercept is available from a variety of vendors in a variety of nations, including the Y, Y, and Y. The leading producers and distributors are headquartered in India, owing to the availability of raw ingredients for the manufacturing process and low labor costs. Etanercept was first licensed by the FDA in 1998 for the treatment of signs and symptoms of moderately to severely active rheumatoid arthritis in the United States under the brand name Enbrel, Erelzi Prefilled Syringe, ErelziSensoready Pen, Enbrel SureClick, Enbrel Prefilled Syringe, and Enbrel Mini Prefilled Cartridge are some of the commercial names for the medicine, which is currently approved in several countries.

Etanercept works by inhibiting TNF-alpha, a pro-inflammatory cytokine that is increased in conditions such as psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis.

In the United States, the wholesale cost of medication is around $2,910 for a supply of four subcutaneous kits containing 25 mg of the drug each. The retail price of this drug's 25 mg injection solution in a pre-filled syringe in the EU is roughly 540 EUR. Depending on the source, wholesale prices and commercial terms may differ.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Etanercept offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturers and this substance suppliers that you are looking for. These also enable you to check the dossier status ofthis medicine, and the GMP approvals of the different variants of Etanercept. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Etanercept is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offer with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are on boarded on the platform. This allows us to screen Etanercept manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.